Govoptes

HR 661 · MIRACLE Medical Technology Act of 2025

Referred to the House Committee on Energy and Commerce.

Introduced
Jan 23, 2025
Latest action
Jan 23, 2025
Sponsor
Rep. Vern Buchanan [R-FL-16]
Policy area
Health
Cosponsors
3

Summary

Maximizing Israel-U.S. Research Advancement and Collaborative Leadership in Emerging Medical Technology Act of 2025 or the MIRACLE Medical Technology Act of 2025 This bill requires the Department of Health and Human Services (HHS) to implement a program for the United States and Israel to collaborate on developing and delivering health care products and services. The program must include coordinated activities in specified areas, including research and development, use of innovative technology, intellectual property protection, regulatory harmonization, disease prevention, and biological product manufacturing. The bill authorizes HHS to establish a joint United States-Israel Health Care Collaboration Center in the United States to leverage existing expertise for advancing the program’s purposes.

Recent actions

  1. Jan 23, 2025 Referred to the House Committee on Energy and Commerce.
  2. Jan 23, 2025 Introduced in House
  3. Jan 23, 2025 Introduced in House

Votes

No recorded votes are available for this bill.

Related pages